Recent technical breakthroughs in engineering human somatic cells to induce pluripotent stem cells or directly convert into another cell type offer unprecedented opportunities for regenerative medicine. These relatively novel research tools, commonly referred to as cell fate reprogramming, allow derivation of individual-specific stem cells or differentiated cell types geared towards developing disease models of inherited diseases or cell replacement-based therapeutic approaches. Additionally, human embryonic stem cell lines that have been approved as experimental tools can be used to study genetic pathways underlying cellular differentiations. Towards these goals, faculties in the department use human cells to study genetic pathways that govern cellular differentiation, develop experimental protocols for deriving various cell types for disease modeling or functional rescue of cellular functions lost in diseased states.
Congratulations to Dr. Kerry Kornfeld's Lab on their recent publication! Cell cycle accumulation of the proliferating cell nuclear antigen PCN-1 transitions from continuous in…
Congratulations to Dr. Lila Solnica-Krezel's Lab on their recent publication! Atypical Cadherin Dachsous1b Interacts with Ttc28 and Aurora B to Control Microtubule Dynamics…